PETMED EXPRESS INC (PETS)       18.95  +0.09 (+0.48%)

18.95  +0.09 (+0.48%)

US7163821066 - Common Stock - After market: 18.95 0 (0%)


Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PETS. PETS was compared to 85 industry peers in the Internet & Direct Marketing Retail industry. While PETS has a great health rating, its profitability is only average at the moment. PETS has a expensive valuation and it also scores bad on growth




Profitability

Profitability Rating

6

PETS's Return On Assets of 9.26% is amongst the best returns of the industry. PETS outperforms 92% of its industry peers. The industry average Return On Assets is -10.01%.
PETS has a Profit Margin of 5.98%. This is amongst the best returns in the industry. The industry average is -9.55%. PETS outperforms 91% of its industry peers.

PETS has a Return On Equity of 11.35%. This is comparable to the industry average of 11.35%.
The Piotroski-F score of PETS is 5.00. This is a neutral score and indicates average health and profitability for PETS.
VS Industry

ROA (9.26%) VS Industry: 92% outperformed.

-510.15
22.89

ROE (11.35%) VS Industry: 52% outperformed.

0.22
110.84

Profit Margin (5.98%) VS Industry: 91% outperformed.

-520.03
30.44

Valuation

Valuation Rating

1

The Price/Earnings Ratio is 24.29, which indicates a rather expensive current valuation of PETS.
With a Forward Price/Earnings Ratio of 16.89, PETS is valued correctly.
With a price book ratio of 2.89, PETS is valued correctly.

PETS's Price/Earning Ratio is slightly more expensive than the industry average, which is at 13.38.
Compared to an average industry price book ratio of 1.81, PETS is valued more expensive than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of PETS to the average industry ratio of 10.74, PETS is valued more expensive than its industry peers.
VS Industry

Price/Earnings (24.29) VS Industry: 39% outperformed.

159.61
1.07

Price/Book (2.89) VS Industry: 36% outperformed.

151.13
0.13

Enterprise Value/ EBITDA (14.43) VS Industry: 36% outperformed.

3,220.61
0.21

Growth

Growth Rating

3

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
PETS shows a decrease in Earnings Per Share. Measured over the last 5 years, the EPS has been decreasing by -2.34% yearly.
Based on estimates for the next 5 years, PETS will show a small growth in Earnings Per Share. The EPS will grow by 0.77% on average per year.
The Revenue has decreased by -7.73% in the past year.

PETS shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 1.87% yearly.
PETS is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 0.81% yearly.
The earnings per share for PETS have decreased strongly by -39.53% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS-2.34% -16.27% -39.53% -13.43% 1.93% -1.72% 0.77%
Revenue1.87% -1.19% -7.73% -2.57% 1.34% 1.34% 0.81%

Health

Health Rating

9

PETS has a Current Ratio of 4.52. This indicates that PETS is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of PETS is much better than the industry average of 1.77. PETS has a better rating than 95% of its industry peers.
PETS has a Quick Ratio of 3.41. This indicates that PETS is financially healthy and has no problem in meeting its short term obligations.
The Quick Ratio of PETS is much better than the industry average of 1.11. PETS has a better rating than 93% of its industry peers.

With a Debt to Equity ratio of 0.00, PETS is doing better than the averages in the industry. The industry average is at 0.16.
An Altman-Z score of 11.59 indicates that PETS is not in any danger for bankruptcy at the moment.
PETS has one of the better Altman-Z scores in its industry. It is much better than the industry average of 1.58. PETS has a better score than 100% of its industry peers.
PETS has a Piotroski-F score of 5.00. This indicates an average health and profitability for PETS.
VS Industry

Debt/Equity (0) VS Industry: 65% outperformed.

38.00
0.00

Quick Ratio (3.41) VS Industry: 93% outperformed.

0.04
9.90

Current Ratio (4.52) VS Industry: 95% outperformed.

0.11
9.90

Altman-Z (11.59) VS Industry: 100% outperformed.

-34.75
11.59

Dividend

Dividend Rating

6

PETS has a Yearly Dividend Yield of 6.04%, which is a nice return.
PETS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
PETS has paid a dividend for at least 10 years, which is a reliable track record.
Compared to an average industry Dividend Yield of 6.04, PETS has a dividend in line with its industry peers.

The dividend of PETS has a limited annual growth rate of 4.22%.
PETS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
155.84% of the earnings are spent on dividend by PETS. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (6.04%) VS Industry: 50% outperformed.

1.95
22.87
PETS Daily chart

PETMED EXPRESS INC18.95

NASDAQ:PETS (12/8/2022, 3:05:45 PM)+0.09 (+0.48%)

After market: 18.95 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Retailing
GICS Industry Internet & Direct Marketing Retail
Earnings (Last) N/A N/A Earnings (Next) 01-23 2023-01-23/amc
Ins Owners 0.98% Inst Owners 78.23%
Market Cap 399.38M Analysts 50
Valuation
PE 24.29 Fwd PE 16.89
PEG (NY) N/A PEG (5Y) N/A
P/S 1.52 P/B 2.89
EV/EBITDA 14.43
Dividend
Dividend Yield 6.04% Dividend Growth 4.22%
DP 155.84% Ex-Date 11-17 2022-11-17 (0.3)
Growth
EPS 1Y -39.53% EPS 3Y -16.27%
EPS 5Y -2.34% EPS growth Q2Q -58.06%
EPS Next Y -13.43% EPS Next 2Y 1.93%
EPS Next 3Y -1.72% EPS Next 5Y 0.77%
Revenue growth 1Y -7.73% Revenue growth 3Y -1.19%
Revenue growth 5Y 1.87% Revenue growth Q2Q -2.96%
Revenue Next Year -2.57% Revenue Next 2Y 1.34%
Revenue Next 3Y 1.34% Revenue Next 5Y 0.81%
Health
Current Ratio 4.52 Quick Ratio 3.41
Altman-Z 11.59 F-Score 5
Debt/Equity 0 WACC 9.96%
ROIC/WACC 4.03
Profitability
ROA 9.26% ROE 11.35%
ROICexgc 40.09% ROIC 10.49%
PM 5.98% OM 7.11%
Asset Turnover 1.55

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA